GlassScriptPhysician profile
Jessica Board
NPI 1164970919
$1,540.41
in general payments reported to CMS, 2019-2025
11 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $566 · 2022: $255 · 2023: $284 · 2024: $294 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $566.64 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Vanta Adaptivestim |
| Ethicon US, LLC | $437.64 | 2021 | |
| Boston Scientific Corporation | $173.58 | 2022-2024 | Intracept |
| Saluda Medical Americas, INC. | $114.02 | 2024 | Evoke |
| Medical Device Business Services, INC. | $109.50 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $40.50 | 2021-2024 | Iovera |
| Mml US, INC. | $24.79 | 2025 | Reactiv8 |
| Averitas Pharma INC. | $23.40 | 2025 | Qutenza |
| Relievant Medsystems, INC. | $21.01 | 2023 | Intracept |
| Curonix LLC | $17.39 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $11.94 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Board listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.